1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of ABL1 mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression ISO RGD:1332211 6480464 1, 2-Dimethylhydrazine results in increased expression of ABL1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1332211 6480464 Ethinyl Estradiol affects the expression of ABL1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1332211 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABL1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1332211 6480464 Ethinyl Estradiol results in increased expression of ABL1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1342972 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ABL1 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332211 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABL1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABL1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1332211 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABL1 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1332211 6480464 Tetrachlorodibenzodioxin results in increased expression of ABL1 mRNA CTD PMID:17942748 2-methylcholine affects expression ISO RGD:1342972 6480464 beta-methylcholine affects the expression of ABL1 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of ABL1 mRNA CTD PMID:28970181 4-hydroperoxycyclophosphamide increases expression ISO RGD:1332211 6480464 perfosfamide results in increased expression of ABL1 mRNA CTD PMID:19429390 4-nitroquinoline N-oxide increases expression ISO RGD:1332211 6480464 4-Nitroquinoline-1-oxide results in increased expression of ABL1 mRNA CTD PMID:22561872 4-nitroquinoline N-oxide decreases expression ISO RGD:1332211 6480464 4-Nitroquinoline-1-oxide results in decreased expression of ABL1 mRNA CTD PMID:22561872 4-phenylcoumarin increases expression ISO RGD:1332211 6480464 4-phenylcoumarin analog results in increased expression of ABL1 mRNA CTD PMID:27773722 acetaldehyde multiple interactions ISO RGD:1342972 6480464 ABL1 protein promotes the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein], Imatinib Mesylate inhibits the reaction [Acetaldehyde results in increased activity of ABL1 protein] CTD PMID:17030193 acetaldehyde increases activity ISO RGD:1342972 6480464 Acetaldehyde results in increased activity of ABL1 protein CTD PMID:17030193 AICA ribonucleotide multiple interactions ISO RGD:1342972 6480464 AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to BECN1 protein] more ... CTD PMID:33070465 all-trans-retinoic acid increases expression ISO RGD:1332211 6480464 Tretinoin results in increased expression of ABL1 mRNA CTD PMID:16788091 all-trans-retinoic acid multiple interactions ISO RGD:1342972 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of ABL1 mRNA CTD PMID:15894607 alvocidib multiple interactions ISO RGD:1342972 6480464 [alvocidib co-treated with Bortezomib co-treated with ABL1 protein] results in decreased phosphorylation of LYN protein more ... CTD PMID:15039284 amiodarone increases expression ISO RGD:1342972 6480464 Amiodarone results in increased expression of ABL1 mRNA CTD PMID:19774075 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of ABL1 protein CTD PMID:16483693 arsenous acid decreases expression ISO RGD:1342972 6480464 Arsenic Trioxide results in decreased expression of ABL1 mRNA more ... CTD PMID:10648417 more ... arsenous acid affects response to substance ISO RGD:1342972 6480464 ABL1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 arsenous acid multiple interactions ISO RGD:1342972 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ABL1 protein more ... CTD PMID:15894607 more ... ATP multiple interactions ISO RGD:1342972 6480464 [ABL1 protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein, sorafenib inhibits the reaction [[ABL1 protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein] CTD PMID:19366808 ATP increases chemical synthesis ISO RGD:1342972 6480464 ABL1 protein mutant form results in increased chemical synthesis of Adenosine Triphosphate CTD PMID:33070465 atropine multiple interactions ISO RGD:1342972 6480464 [Parathion co-treated with Atropine] results in increased expression of ABL1 mRNA CTD PMID:17390078 belinostat decreases expression ISO RGD:1342972 6480464 belinostat results in decreased expression of ABL1 mRNA CTD PMID:19606018 benzo[a]pyrene affects methylation ISO RGD:1342972 6480464 Benzo(a)pyrene affects the methylation of ABL1 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1342972 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression ISO RGD:1332211 6480464 bisphenol A results in increased expression of ABL1 mRNA, bisphenol A results in increased expression of ABL1 protein CTD PMID:23704952 more ... bisphenol A decreases methylation ISO RGD:1342972 6480464 bisphenol A results in decreased methylation of ABL1 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1342972 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of ABL1 gene CTD PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ABL1 mRNA CTD PMID:25181051 bortezomib multiple interactions ISO RGD:1342972 6480464 [alvocidib co-treated with Bortezomib co-treated with ABL1 protein] results in decreased phosphorylation of LYN protein more ... CTD PMID:15039284 more ... bosutinib decreases activity ISO RGD:1342972 6480464 bosutinib results in decreased activity of ABL1 protein CTD PMID:17114238 butanal decreases expression ISO RGD:1342972 6480464 butyraldehyde results in decreased expression of ABL1 mRNA CTD PMID:26079696 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of ABL1 mRNA CTD PMID:19167457 cadmium dichloride multiple interactions ISO RGD:1332211 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ABL1 mRNA CTD PMID:19840844 caffeine affects phosphorylation ISO RGD:1342972 6480464 Caffeine affects the phosphorylation of ABL1 protein CTD PMID:35688186 calcitriol increases expression ISO RGD:1342972 6480464 Calcitriol results in increased expression of ABL1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1342972 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ABL1 mRNA CTD PMID:21592394 capsaicin increases expression ISO RGD:1342972 6480464 Capsaicin results in increased expression of ABL1 mRNA CTD PMID:19502594 CGP 52608 multiple interactions ISO RGD:1342972 6480464 CGP 52608 promotes the reaction [RORA protein binds to ABL1 gene] CTD PMID:28238834 chloroquine multiple interactions ISO RGD:1342972 6480464 Chloroquine promotes the reaction [ABL1 protein mutant form binds to BECN1 protein], Chloroquine promotes the reaction [ABL1 protein mutant form binds to YWHAQ protein] CTD PMID:33070465 cisplatin multiple interactions ISO RGD:1342972 6480464 [[[Cisplatin co-treated with 2 more ... CTD PMID:21214929 more ... cisplatin decreases expression ISO RGD:1342972 6480464 Cisplatin results in decreased expression of ABL1 mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ABL1 protein CTD PMID:22023808 cisplatin increases response to substance ISO RGD:1342972 6480464 ABL1 protein results in increased susceptibility to Cisplatin CTD PMID:21324906 cocaine affects expression ISO RGD:1332211 6480464 Cocaine affects the expression of ABL1 mRNA CTD PMID:15681117 copper atom multiple interactions ISO RGD:1342972 6480464 [Thiosemicarbazones binds to Copper] which results in increased expression of ABL1 protein CTD PMID:20931265 copper(0) multiple interactions ISO RGD:1342972 6480464 [Thiosemicarbazones binds to Copper] which results in increased expression of ABL1 protein CTD PMID:20931265 coumarin decreases phosphorylation ISO RGD:1342972 6480464 coumarin results in decreased phosphorylation of ABL1 protein CTD PMID:35688186 crizotinib decreases activity ISO RGD:1332211 6480464 crizotinib results in decreased activity of ABL1 protein CTD PMID:21812414 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ABL1 mRNA CTD PMID:27523638 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA CTD PMID:29038839 cytochalasin D multiple interactions ISO RGD:1332211 6480464 EGF protein inhibits the reaction [Cytochalasin D results in increased phosphorylation of ABL1 protein] CTD PMID:21900236 cytochalasin D increases phosphorylation ISO RGD:1332211 6480464 Cytochalasin D results in increased phosphorylation of ABL1 protein CTD PMID:21900236 daunorubicin decreases response to substance ISO RGD:1342972 6480464 ABL1 results in decreased susceptibility to Daunorubicin CTD PMID:12410571 diarsenic trioxide decreases expression ISO RGD:1342972 6480464 Arsenic Trioxide results in decreased expression of ABL1 mRNA more ... CTD PMID:10648417 more ... diarsenic trioxide multiple interactions ISO RGD:1342972 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ABL1 protein more ... CTD PMID:15894607 more ... diarsenic trioxide affects response to substance ISO RGD:1342972 6480464 ABL1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 dicrotophos increases expression ISO RGD:1342972 6480464 dicrotophos results in increased expression of ABL1 mRNA CTD PMID:28302478 dioxygen increases metabolic processing ISO RGD:1342972 6480464 ABL1 protein mutant form results in increased metabolism of Oxygen CTD PMID:33070465 doxorubicin multiple interactions ISO RGD:1342972 6480464 [[[Doxorubicin co-treated with 2 more ... CTD PMID:21214929 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA CTD PMID:29038839 fulvestrant multiple interactions ISO RGD:1342972 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of ABL1 gene CTD PMID:31601247 gallic acid multiple interactions ISO RGD:1342972 6480464 Gallic Acid promotes the reaction [Imatinib Mesylate results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]] more ... CTD PMID:22245431 genistein increases expression ISO RGD:1332211 6480464 Genistein results in increased expression of ABL1 mRNA CTD PMID:32186404 glyphosate increases expression ISO RGD:1342972 6480464 glyphosate results in increased expression of ABL1 mRNA CTD PMID:31874349 gold atom multiple interactions ISO RGD:1342972 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA CTD PMID:28433809 gold(0) multiple interactions ISO RGD:1342972 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA CTD PMID:28433809 histamine multiple interactions ISO RGD:1342972 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] more ... CTD PMID:16849647 hydrogen peroxide increases activity ISO RGD:1342972 6480464 Hydrogen Peroxide results in increased activity of ABL1 protein CTD PMID:17030193 hydrogen peroxide affects expression ISO RGD:1342972 6480464 Hydrogen Peroxide affects the expression of ABL1 protein CTD PMID:21179406 hydrogen peroxide multiple interactions ISO RGD:1342972 6480464 Imatinib Mesylate inhibits the reaction [Hydrogen Peroxide results in increased activity of ABL1 protein] CTD PMID:17030193 lipopolysaccharide increases expression ISO RGD:1332211 6480464 Lipopolysaccharides results in increased expression of ABL1 mRNA CTD PMID:12057914 LY294002 multiple interactions ISO RGD:1342972 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mRNA] CTD PMID:16849647 mangiferin decreases expression ISO RGD:1342972 6480464 mangiferin results in decreased expression of ABL1 mRNA CTD PMID:15498116 mercury atom increases expression ISO RGD:1342972 6480464 Mercury results in increased expression of ABL1 mRNA CTD PMID:19937285 mercury(0) increases expression ISO RGD:1342972 6480464 Mercury results in increased expression of ABL1 mRNA CTD PMID:19937285 metformin multiple interactions ISO RGD:1342972 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of ABL1 mRNA CTD PMID:29309887 methamphetamine increases expression ISO RGD:1332211 6480464 Methamphetamine results in increased expression of ABL1 mRNA CTD PMID:26307267 methylmercury chloride increases expression ISO RGD:1332211 6480464 methylmercuric chloride results in increased expression of ABL1 mRNA CTD PMID:20061341 myristicin decreases expression ISO RGD:1342972 6480464 myristicin results in decreased expression of ABL1 mRNA CTD PMID:24792648 Myrtucommulone A decreases expression ISO RGD:1332211 6480464 myrtucommulone A results in decreased expression of ABL1 mRNA CTD PMID:26032814 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:1342972 6480464 N more ... CTD PMID:12756304 N,N-dimethylsphingosine multiple interactions ISO RGD:1342972 6480464 [Bortezomib co-treated with N, N-dimethylsphingosine] results in decreased expression of ABL1 protein CTD PMID:21195056 N-acetyl-L-cysteine multiple interactions ISO RGD:1332211 6480464 Acetylcysteine inhibits the reaction [NSC 680410 results in decreased phosphorylation of ABL1 protein] CTD PMID:16481037 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1332211 6480464 1-Methyl-4-phenylpyridinium promotes the reaction [ABL1 protein binds to and results in increased phosphorylation of and results in increased activity of GSK3B protein], 1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in increased activity of ABL1 protein CTD PMID:30165626 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:1332211 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ABL1 mRNA more ... CTD PMID:19840844 nilotinib decreases phosphorylation ISO RGD:1342972 6480464 nilotinib results in decreased phosphorylation of ABL1 protein, nilotinib results in decreased phosphorylation of ABL1 protein mutant form CTD PMID:19878872 , PMID:23883479 nilotinib multiple interactions ISO RGD:1342972 6480464 [nilotinib co-treated with Arsenic Trioxide] results in decreased phosphorylation of ABL1 protein more ... CTD PMID:16849647 more ... Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1342972 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of ABL1 gene CTD PMID:30521419 okadaic acid multiple interactions ISO RGD:1332211 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ABL1 mRNA CTD PMID:19840844 paclitaxel multiple interactions ISO RGD:1342972 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of ABL1 mRNA CTD PMID:29309887 panobinostat multiple interactions ISO RGD:1342972 6480464 [Cisplatin co-treated with panobinostat] affects the expression of ABL1 mRNA CTD PMID:21791302 paracetamol affects expression ISO RGD:1332211 6480464 Acetaminophen affects the expression of ABL1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ABL1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1342972 6480464 Acetaminophen results in increased expression of ABL1 mRNA CTD PMID:29067470 paraquat increases expression ISO RGD:1342972 6480464 Paraquat results in increased expression of ABL1 mRNA CTD PMID:18836921 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ABL1 mRNA CTD PMID:32680482 parathion multiple interactions ISO RGD:1342972 6480464 [Parathion co-treated with Atropine] results in increased expression of ABL1 mRNA CTD PMID:17390078 parathion increases expression ISO RGD:1342972 6480464 Parathion results in increased expression of ABL1 mRNA CTD PMID:17390078 phenobarbital decreases methylation ISO RGD:1332211 6480464 Phenobarbital results in decreased methylation of ABL1 gene, Phenobarbital results in decreased methylation of ABL1 promoter CTD PMID:19233941 , PMID:19482888 phenobarbital increases expression ISO RGD:1332211 6480464 Phenobarbital results in increased expression of ABL1 mRNA CTD PMID:19482888 phenylephrine multiple interactions EXP 6480464 ABL1 protein affects the reaction [Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein]] more ... CTD PMID:17615370 phenylephrine increases phosphorylation EXP 6480464 Phenylephrine results in increased phosphorylation of ABL1 protein CTD PMID:17615370 phenylephrine affects response to substance EXP 6480464 ABL1 protein affects the susceptibility to Phenylephrine CTD PMID:17615370 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1332211 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ABL1 mRNA CTD PMID:19840844 platycodin D multiple interactions ISO RGD:1342972 6480464 [platycodin D co-treated with Imatinib Mesylate] results in decreased expression of ABL1 protein CTD PMID:29552859 ponatinib multiple interactions ISO RGD:1342972 6480464 ponatinib inhibits the reaction [ABL1 protein mutant form results in increased phosphorylation of ABL1 protein mutant form] more ... CTD PMID:19878872 ponatinib decreases phosphorylation ISO RGD:1342972 6480464 ponatinib results in decreased phosphorylation of ABL1 protein, ponatinib results in decreased phosphorylation of ABL1 protein mutant form CTD PMID:19878872 , PMID:25304212 ponatinib decreases activity ISO RGD:1342972 6480464 ponatinib analog results in decreased activity of ABL1 protein more ... CTD PMID:19878872 more ... potassium chloride multiple interactions EXP 6480464 ABL1 protein affects the reaction [Potassium Chloride results in increased phosphorylation of BCAR1 protein] CTD PMID:17615370 potassium chloride increases phosphorylation EXP 6480464 Potassium Chloride results in increased phosphorylation of ABL1 protein CTD PMID:17615370 potassium chloride affects response to substance EXP 6480464 ABL1 protein affects the susceptibility to Potassium Chloride CTD PMID:17615370 psoralen affects binding ISO RGD:1342972 6480464 Ficusin binds to ABL1 protein CTD PMID:35597499 purmorphamine multiple interactions ISO RGD:1342972 6480464 purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]] CTD PMID:22397755 quercetin decreases expression ISO RGD:1342972 6480464 Quercetin results in decreased expression of ABL1 protein CTD PMID:19207037 resveratrol multiple interactions ISO RGD:1342972 6480464 purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]], resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] CTD PMID:22397755 rottlerin multiple interactions ISO RGD:1342972 6480464 rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] CTD PMID:17030193 sodium arsenite increases expression ISO RGD:1342972 6480464 sodium arsenite results in increased expression of ABL1 mRNA CTD PMID:12016162 sodium arsenite decreases expression ISO RGD:1332211 6480464 sodium arsenite results in decreased expression of ABL1 mRNA CTD PMID:16014739 sorafenib multiple interactions ISO RGD:1342972 6480464 sorafenib inhibits the reaction [[ABL1 protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein] CTD PMID:19366808 sorafenib decreases activity ISO RGD:1342972 6480464 sorafenib results in decreased activity of ABL1 protein mutant form CTD PMID:19366808 sorafenib decreases phosphorylation ISO RGD:1342972 6480464 sorafenib results in decreased phosphorylation of ABL1 protein mutant form CTD PMID:19366808 tamoxifen affects expression ISO RGD:1332211 6480464 Tamoxifen affects the expression of ABL1 mRNA CTD PMID:17555576 tamoxifen decreases response to substance ISO RGD:1342972 6480464 ABL1 protein results in decreased susceptibility to Tamoxifen CTD PMID:20234815 testosterone increases expression ISO RGD:1342972 6480464 Testosterone results in increased expression of ABL1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1342972 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ABL1 mRNA CTD PMID:21592394 tetrachloromethane increases phosphorylation ISO RGD:1342972 6480464 Carbon Tetrachloride results in increased phosphorylation of ABL1 protein CTD PMID:17030193 tetrachloromethane multiple interactions ISO RGD:1342972 6480464 Imatinib Mesylate inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of ABL1 protein] CTD PMID:17030193 trichostatin A decreases expression ISO RGD:1342972 6480464 trichostatin A results in decreased expression of ABL1 mRNA CTD PMID:19606018 , PMID:23770000 triptonide affects expression ISO RGD:1332211 6480464 triptonide affects the expression of ABL1 mRNA CTD PMID:33045310 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions ISO RGD:1342972 6480464 [Parathion co-treated with Atropine] results in increased expression of ABL1 mRNA CTD PMID:17390078 tungsten decreases expression ISO RGD:1332211 6480464 Tungsten results in decreased expression of ABL1 mRNA CTD PMID:30912803 valproic acid increases expression ISO RGD:1332211 6480464 Valproic Acid results in increased expression of ABL1 mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:1342972 6480464 Valproic Acid affects the expression of ABL1 mRNA CTD PMID:25979313 vanadium atom increases expression ISO RGD:1342972 6480464 Vanadium results in increased expression of ABL1 mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:1342972 6480464 Vanadium results in increased expression of ABL1 mRNA CTD PMID:19000753 vorinostat multiple interactions ISO RGD:1342972 6480464 [Dasatinib co-treated with Vorinostat] results in decreased expression of ABL1 protein mutant form more ... CTD PMID:12446442 more ... vorinostat decreases expression ISO RGD:1342972 6480464 vorinostat results in decreased expression of ABL1 mRNA mutant form, vorinostat results in decreased expression of ABL1 protein mutant form CTD PMID:12446442 zinc atom affects expression ISO RGD:1342972 6480464 Zinc affects the expression of ABL1 protein CTD PMID:16636310 zinc(0) affects expression ISO RGD:1342972 6480464 Zinc affects the expression of ABL1 protein CTD PMID:16636310
